Company intelligence / Profile preview

OneLife

Ownership: Private
Development stage: Commercial

Overview

OneLife develops, manufactures, and markets proprietary enzyme-based cleaning solutions designed to break down biofilms on medical devices and critical healthcare surfaces. Their technology enables complete removal of organic soil/biofilms, supporting effective disinfection protocols to prevent healthcare-associated infections and combat antimicrobial resistance. Their products are tested against a broad spectrum of bacterial strains in clinical settings.

Therapeutic areas: Infectious Diseases
Modalities: Enzymatic cleaning solutionsBiologic
Industry: Consumable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on OneLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OneLife.

Explore the full profile